Hep Email Update Testing People With Diabetes Can Detect More Liver Disease Using a two-part testing plan could help identify those with advanced liver fibrosis among people with type 2 diabetes. Advertisement Cotadutide Improves NASH Biomarkers in Overweight People With Diabetes The experimental drug led to significant reduction in body weight but was accompanied by nausea and vomiting. The Danger of Assuming With Hepatitis C False assumptions can lead people to believe they don’t need to be tested or get treatment for hepatitis C. Abnormal Liver Tests Linked to Worse COVID-19 Outcomes The prevalence of abnormal liver tests in people hospitalized with COVID-19 is higher than previously found. #Coronavirus Get the latest updates! Positively Empowering In honor of Hep commemorating 10 years, we are spotlighting 10 inspiring activists: Gloria Searson keeps changing the way people think about hep C. Advertisement Treatment News Cotadutide Improves NASH Biomarkers in Overweight People With Diabetes Abnormal Liver Tests Linked to Worse COVID-19 Outcomes Many People on Medicaid and Prisoners Still Lack Access to Hepatitis C Treatment Aldafermin Improves Fibrosis in People With NASH Substance Use Disorders Linked to Increased COVID-19 Risk Testing People With Diabetes Can Detect More Liver Disease Features Positively Empowering Who Is Most Susceptible to COVID-19? Perseverance Continued Turning Anger Into Action Living to Tell Staying Alive Treatment News Cotadutide Improves NASH Biomarkers in Overweight People With Diabetes Abnormal Liver Tests Linked to Worse COVID-19 Outcomes Many People on Medicaid and Prisoners Still Lack Access to Hepatitis C Treatment Aldafermin Improves Fibrosis in People With NASH Substance Use Disorders Linked to Increased COVID-19 Risk Testing People With Diabetes Can Detect More Liver Disease Features Positively Empowering Who Is Most Susceptible to COVID-19? Perseverance Continued Turning Anger Into Action Living to Tell Staying Alive

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: